Alnylam Pharmaceuticals
ALNY
#485
Rank
โ‚น4.418 T
Marketcap
โ‚น33,446
Share price
-6.87%
Change (1 day)
50.26%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company